Synapse - Works

Results (115370)

Validation of the Molecular International Prognostic Scoring System (IPSS-M) in patients (pts) with myelodysplastic syndromes/neoplasms (MDS) who were treated with hypomethylating agents (HMA)

Meeting Abstract

Kewan, T.; Bewersdorf, J. P.; Blaha, O.; Stahl, M.; Ali, N. H.; DeZern, A. E.; Sekeres, M. A.; Carraway, H. E.; Desai, P.; Griffiths, E. A.; more...
Blood (2023)

Fulltext@MSK | Save

Selinexor, ixazomib, pomalidomide and dexamethasone in functionally high-risk multiple myeloma: Results from the Myeloma Developing Regimens Using Genomics (MyDRUG) sub-protocol Y3

Meeting Abstract

Richter, J.; Zonder, J. A.; Nathwani, N.; Bianchi, G.; Hofmeister, C. C.; Vij, R.; Pianko, M.; Kaur, G.; Hultcrantz, M.; Wozniak, K.; more...
Blood (2023)

Fulltext@MSK | Save

Beat AML S8 Group 2: Gilteritinib (GILT) in combination with decitabine (DEC) and venetoclax (VEN) in untreated FLT3 mutated acute myeloid leukemia (AML) patients age ≥60 with high and low variant allele frequency (VAF)

Meeting Abstract

Liu, Q.; Welkie, R. L.; Huang, Y.; Swords, R. T.; Lin, T. L.; Koenig, K. L.; Madanat, Y. F.; Patel, P. A.; Collins, R. H.; Blum, W.; more...
Blood (2023)

Fulltext@MSK | Save

Deciphering the clinical benefit of Pola-R-CHP versus R-CHOP in different genetic subtypes beyond cell of origin in the POLARIX study

Meeting Abstract

Morschhauser, F.; Leung, W.; Raghavan, V.; Lenz, G.; Jardin, F.; Herrera, A. F.; Sehn, L. H.; Sharman, J. P.; Flowers, C. R.; Friedberg, J. W.; more...
Blood (2023)

Fulltext@MSK | Save

CD33-TIM3 dual CAR T cells: Enhancing specificity while maintaining efficacy against AML

Meeting Abstract

Wang, Y.; Lu, W.; Rohrbacher, L.; Flaswinkel, H.; Emhardt, A. J.; Magno, G.; Haubner, S.; Kobold, S.; Leonhardt, H.; Hopfner, K. P.; more...
Blood (2023)

Fulltext@MSK | Save

Tazemetostat in combination with lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma: Updated phase 1b results of SYMPHONY-1 with 22.5 months follow-up

Meeting Abstract

Salles, G.; Park, S. I.; Phillips, T. J.; Amengual, J. E.; Andorsky, D. J.; Campbell, P.; McKay, P.; Leonard, J. P.; Chen, Y. X.; Chen, J. D.; more...
Blood (2023)

Fulltext@MSK | Save

Strategies to develop anti-KIR mab lacutamab in patients with peripheral T-cell lymphoma: Preliminary monotherapy clinical data and pre-clinical combinability data

Meeting Abstract

Iyer, S. P.; Ayyappan, S. R.; Greenwell, I. B.; Kim, W. S.; Lee, S. T.; Kim, J. S.; Lee, W. S.; Jeon, Y.; Johnson, W.; Dave, U. P.; more...
Blood (2023)

Fulltext@MSK | Save

Primary endpoint analysis from a response adaptive phase II clinical trial of carfilzomib, lenalidomide, dexamethasone plus daratumumab (KRd-Dara) in patients with newly diagnosed multiple myeloma (NDMM)

Meeting Abstract

Bhutani, M.; Robinson, M.; Atrash, S.; Paul, B.; Pineda-Roman, M.; Foureau, D.; Varga, C.; Friend, R.; Begic, X.; Norek, S.; more...
Blood (2023)

Fulltext@MSK | Save

Safety and preliminary efficacy of DFV890 in adult patients with myeloid diseases: A phase 1b study

Meeting Abstract

Garcia-Manero, G.; Ooi, M.; Lao, Z. T.; Gill, H.; Abaza, Y.; Stahl, M.; Haque, T.; DeZern, A. E.; Greenberg, P. L.; Pelletier, M.; more...
Blood (2023)

Fulltext@MSK | Save

Clinical factors associated with cytokine release syndrome and dosing recommendations for restarting elranatamab following an interruption

Meeting Abstract

Niesvizky, R.; Arnulf, B.; Mohty, M.; Nooka, A. K.; Manier, S.; Tomasson, M.; Bahlis, N. J.; Irby, D.; Hibma, J.; Viqueira, A.; more...
Blood (2023)

Fulltext@MSK | Save